<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371570">
  <stage>Registered</stage>
  <submitdate>29/09/2016</submitdate>
  <approvaldate>4/10/2016</approvaldate>
  <actrnumber>ACTRN12616001371482</actrnumber>
  <trial_identification>
    <studytitle>Genetic link between Fibrous Dysplasia and Intramuscular Myxoma in patients suffering from Mazabraud syndrome</studytitle>
    <scientifictitle>Genetic link between Fibrous Dysplasia and Intramuscular Myxoma in Mazabraud syndrome</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Mazabraud syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>4 cases of Mazabraud syndrome will be asked to give blood sample in pathology for genetic study.. Only a single blood sample will be taken from each participant.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Early Detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Finding common genetic mutations in patient suffering from both Fibrous Dysplasia and Intramuscular Myxoma, known as Mazabraud syndrome </outcome>
      <timepoint>One blood sample will be taken.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Knowing common genetic mutations will help in distinguishing fibrous dysplesia from malignant tumours </outcome>
      <timepoint>One blood sample will be taken.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Detecting those mutations which lead to fibrous dysplasia in those who are suffering from multiple intramuscular myxoma</outcome>
      <timepoint>One blood sample will be taken.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with confirmed diagnosis of both Intramuscular Myxoma and Fibrous Dysplesia (which is known as Mazabraud syndrome)</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>1</followup>
    <followuptype>Hours</followuptype>
    <purposeobs />
    <duration />
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/12/2016</anticipatedstartdate>
    <actualstartdate>1/06/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>4</samplesize>
    <actualsamplesize />
    <currentsamplesize>1</currentsamplesize>
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>Hollywood Private Hospital - Nedlands</hospital>
    <postcode>6009 - Nedlands</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Hollywood Private Hospital</primarysponsorname>
    <primarysponsoraddress>Monash Avenue, Nedlands, WA 6009</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Hollywood Private Hospital</fundingname>
      <fundingaddress>Monash Avenue, Nedlands, WA 6009</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Mazabrauds syndrome is a rare syndrome in which benign intramuscular myxomas occur in association with fibrous dysplasia of bone. (Macfarlane, Lew et al. 2007)
There is increased risk of developing osteosarcoma or fibrosarcoma in Fibrous Dysplasia with Mazabraud syndrome. The recognition of this entity is important for appropriate management of the patient.  
In this project, we will perform genetic tests on 4 patients with Mazabraud syndrome to look for any genetic link between Fibrous Dysplasia (FD) and Intramuscular Myxoma (IM). In order to do genetic study, we need to arrange taking blood sample from these patients. 
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Hollywood Private Hospital Ethic Committee</ethicname>
      <ethicaddress>Monash Avenue, Nedlands, WA 6009</ethicaddress>
      <ethicapprovaldate>2/04/2017</ethicapprovaldate>
      <hrec>HPH476</hrec>
      <ethicsubmitdate>4/11/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/371570-HPH476 Final approval letter.pdf</filepath>
  </attachment>
  <contacts>
    <contact>
      <title>Prof</title>
      <name>David Wood</name>
      <address>Perth Orthopaedic Institute
Entrance 6, Verdun Street Nedlands WA 6009</address>
      <phone>+61 8 9386 6211 </phone>
      <fax>+61 8 9346 6462</fax>
      <email>David.wood@uwa.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Mohammad Rasouli</name>
      <address>Perth Orthopaedic Institute
Entrance 6, Verdun Street Nedlands WA 6009</address>
      <phone>+61 420 552 959</phone>
      <fax />
      <email>Rasoulimd1983@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Mohammad Rasouli</name>
      <address>Perth Orthopaedic Institute
Entrance 6, Verdun Street Nedlands WA 6009</address>
      <phone>+61 420 552 959</phone>
      <fax />
      <email>Rasoulimd1983@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Mohammad Rasouli</name>
      <address>Perth Orthopaedic Institute
Entrance 6, Verdun Street Nedlands WA 6009</address>
      <phone />
      <fax />
      <email>Rasoulimd1983@gmail.com</email>
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>